Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032
(2004; 102 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenidoIntroduction
Cerrar esta carpetaReview 1. What attitudes do professional and lay people have to promotion?
Ver el documento1.1 Attitudes do not necessarily match behaviour
Ver el documento1.2 Studies of the prevalence of different attitudes to promotion (excluding direct-to-consumer advertising)
Ver el documento1.3 Do trainers and trainees think that sales representatives should be banned during medical training?
Ver el documento1.4 Do doctors think they have enough training to deal with sales representatives?
Ver el documento1.5 Do doctors think that sales representatives have a valuable role in medical education?
Ver el documento1.6 What do health professionals think about the quality of the information provided by sales representatives and advertisements about drugs?
Ver el documento1.7 What do other groups of people think of promotional information?
Ver el documento1.8 What are doctors’ views of pharmaceutical company support of conferences and speakers?
Ver el documento1.9 Do trainee doctors plan to see sales representatives in their future practice?
Ver el documento1.10 What are professionals’ and patients’ attitudes to the appropriateness of gifts?
Ver el documento1.11 Do health professionals feel that discussions with sales representatives affect prescribing?
Ver el documento1.12 Do people feel that accepting gifts influences prescribing?
Ver el documento1.13 Ethics and promotion
Ver el documento1.14 Attitudes to direct-to-consumer advertising of prescription drugs
Ver el documento1.15 Studies of differences in attitudes to promotion (excluding DTCA)
Ver el documentoSummary of conclusions
Ver el documentoDirections for future research
Abrir esta carpeta y ver su contenidoReview 2. What impact does pharmaceutical promotion have on attitudes and knowledge?
Abrir esta carpeta y ver su contenidoReview 3. What impact does pharmaceutical promotion have on behaviour?
Abrir esta carpeta y ver su contenidoReview 4. What interventions have been tried to counter promotional activities, and with what results?
Ver el documentoFinal conclusions
Ver el documentoReferences

Review 1. What attitudes do professional and lay people have to promotion?

Finding out what people think about promotion, and what effect they think it has on them, is important because it can help us to develop relevant interventions. However, research on this topic cannot provide evidence about the actual effects of promotion. Promotion may affect people in ways that they do not know about, or are reluctant to tell others about.

This review describes studies that examine what people think about promotion. Studies about how people use promotion and other sources of drug information are not included here; these can be found in Review 2.

Research on attitudes to promotion relies heavily on survey methods. It tends to provide estimates of how many people agree with or disagree with certain statements, mostly about the appropriateness and effect of various forms of promotion. There are some more complex studies, which attempt to explore other variables associated with different attitudes to promotion. These try to find out what kinds of people have different opinions on promotion. Such studies are more useful.

There is little qualitative research on people’s attitudes to promotion, and this is a major gap. In order to understand people’s perspectives and values more clearly, in-depth interviews are needed. People should be express themselves in their own way about what they think about promotion and how it affects them. Ethnographic research, in which the researcher spends time with doctors and tries to understand how promotion fits into their working lives, would also be useful.

Ir a la sección anterior
Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 6 diciembre 2017